<unk>  is an orexin receptor antagonist that is FDA approved for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.   Common adverse reactions include somnolence.
Suvorexant
Icatibant
Atogepant
Domiphen
Patiromer
Tasimelteon
Etamivan
Clobenzorex